美国肺康复项目中的运动处方调查。

Survey of Exercise Prescription in US Pulmonary Rehabilitation Programs.

机构信息

Department of Medicine, University of California San Francisco (Mr Garvey); Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California (Dr Casaburi); REVAL-Rehabilitation Research Center, BIOMED-Biomedical Research Institute, Faculty of Rehabilitation Sciences and Physiotherapy, Hasselt University, Diepenbeek, Belgium (Dr Spruit and Ms De Brandt); Department of Research and Education, CIRO+, Center of Expertise for Chronic Organ Failure, Horn, the Netherlands (Dr Spruit); and Department of Respiratory Medicine, Maastricht University Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands (Dr Spruit).

出版信息

J Cardiopulm Rehabil Prev. 2020 Mar;40(2):116-119. doi: 10.1097/HCR.0000000000000467.

DOI:10.1097/HCR.0000000000000467

PMID:32118657

Abstract

PURPOSE

Pulmonary rehabilitation (PR) is the standard of care for chronic, symptomatic lung disease. Current scientific and clinical guidelines recommend PR to improve dyspnea, functional capacity, and quality of life. Several PR guidelines provide recommendations about the mode, intensity, duration, frequency, and progression of exercise-based interventions. There are variations in the components of PR exercise prescription that may influence the response to PR, as well as variations in how the exercise prescription and its components are determined and monitored. Therefore, the purpose of this investigation was to identify current PR exercise prescription practices via survey sent to 1758 PR programs in the United States.

METHODS

The American Association of Cardiovascular and Pulmonary Rehabilitation administered surveys in 2013 and 2016 to US-based PR providers.

RESULTS

Responses were returned from 371 PR providers (vs 380 in 2013). There was an increase in responses for all options describing exercise prescription methodology in the 2016 survey, with each element (frequency, intensity, time [duration], and type [mode]; FITT) demonstrating significant increase in use. There was a significant increase in 3 methods of determining exercise goals in 2016 versus 2013: duration (P = .017), distance (P = .010), and metabolic equivalents of task (P ≤ .001).

CONCLUSIONS

The 2016 survey responses show a greater use of guideline-based exercise prescription methodology, with an increase in use of FITT methodology for exercise prescription.

摘要

目的

肺康复（PR）是慢性、有症状肺部疾病的标准治疗方法。目前的科学和临床指南建议进行 PR 以改善呼吸困难、功能能力和生活质量。几项 PR 指南针对基于运动的干预措施的模式、强度、持续时间、频率和进展提供了建议。PR 运动处方的组成部分存在差异，这可能会影响 PR 的反应，以及运动处方及其组成部分的确定和监测方式也存在差异。因此，本研究的目的是通过向美国 1758 个 PR 项目发送调查来确定当前 PR 运动处方的实践情况。

方法

美国心血管和肺康复协会于 2013 年和 2016 年向美国 PR 提供者进行了调查。

结果

从 371 名 PR 提供者处收到了回复（2013 年为 380 名）。与 2013 年相比，2016 年调查中描述运动处方方法的所有选项的回复均有所增加，每个要素（频率、强度、时间[持续时间]和类型[模式]；FITT）的使用都显著增加。在 2016 年与 2013 年相比，有 3 种确定运动目标的方法显著增加：持续时间（P =.017）、距离（P =.010）和任务代谢当量（P ≤.001）。